Find trials
Search tips

Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers

Overview

About this study

The objectives of this study are to determine feasibility of adherence to a dyad-based PA intervention (# of sessions attended and Halo wear adherence) for HCT recipients and caregivers (15 dyads) using a single-group pre-post design, to determine acceptability of the intervention (dimensions of treatment satisfaction), and to describe patterns of change in PA and communal coping from baseline to follow-up, and in tone across intervention sessions. 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Patients:

  • Age 18+ years.
  • Scheduled to receive an autologous or allogeneic HCT.
  • Have access to a smart phone.
  • Being married or in a committed cohabiting relationship.
  • English speaking and comprehending.
  • Physician approval to participate in a walking program.

Inclusion Criteria - Caregivers:

  • Age 18+ years.
  • Have access to a smart phone.
  • Married to or in a cohabiting relationship with the patient.
  • Able to participate in a walking program.

Exclusion Criteria - Patients:

  • Age < 18 years.
  • Not scheduled to receive an HCT or already post-HCT.
  • Unmarried or not in a committed cohabiting relationship.
  • Non-English speaking and comprehending.
  • Not medically approved to participate in walking program.
  • Enrolled in competing behavioral intervention.

Exclusion Criteria - Caregivers:

  • Age < 18 years.
  • Not married to or partnered/ cohabiting with the patient.
  • Unable to participate in a walking program.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Nandita Khera, M.D., M.P.H.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20527463

Mayo Clinic Footer